Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 36, Issue 1, 2011, Pages 41-47

  Li, Yun Xia ^a,b,c   Ye, Liang Hong ^a,b,c   Jiang, Xue Hua ^d   Peng, Cheng ^a,b,c  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c State Key Laboratory Breeding Base of Systematic Research   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Caco 2 cells; MDR1 MDCKII cells; P gp; Phillyrin; Transportation

Indexed keywords

ELACRIDAR; GLYCOPROTEIN P; HERBACEOUS AGENT; PHILLYRIN; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL STRAIN CACO 2; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DIFFUSION; DRUG POTENTIATION; DRUG TRANSPORT; FORSYTHIA; HUMAN; HUMAN CELL; INHIBITION KINETICS; NONHUMAN;

ABSORPTION; ANIMALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL LINE; DOGS; GLUCOSIDES; HUMANS; MICE; P-GLYCOPROTEIN; TEMPERATURE;

EID: 79954443697     PISSN: 03787966     EISSN: 21070180     Source Type: Journal    
DOI: 10.1007/s13318-011-0026-0     Document Type: Article

References (34)

1. P Acharya TT Tran JW Polli, et al. 2006 P-gp expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites Biochemistry 45 15505 15519 10.1021/bi060593b 17176072 10.1021/bi060593b 1:CAS:528:DC%2BD28Xht1Gjsb3M (Pubitemid 46032474)
2. MDL Ana JAM María FM Lidia, et al. 2001 Lignan and phenylpropanoid glycosides from Phillyrea latifolia and their in vitro anti-inflammatory activity Planta Med 67 219 223 10.1055/s-2001-12004 10.1055/s-2001-12004 (Pubitemid 32304190)
3. P Artursson K Palm K Luthman 2001 Caco-2 monolayers in experimental and theoretical predictions of drug transport Adv Drug Deliv Rev 46 27 43 10.1016/S0169-409X(00)00128-9 11259831 10.1016/S0169-409X(00)00128-9 1:CAS:528:DC%2BD3MXitVOhs7s%3D
4. J Bentz TT Tran JW Polli, et al. 2005 The steady-state Michaelis-Menten analysis of P-glycoprotein mediated transport through a confluent cell monolayer cannot predict the correct Michaelis constant K Pharmacol Res 22 1667 1677 10.1007/s11095-005-6627-z 10.1007/s11095-005-6627-z 1:CAS:528:DC%2BD2MXhtVent7rI (Pubitemid 41355906)
5. XF Chen JY Zhang CX Xue, et al. 2004 Simultaneous determination of some active ingredients in anti-viral preparations of traditional Chinese medicine by micellar electrokinetic chromatography Biomed Chromatogr 18 673 680 10.1002/bmc.373 15386499 10.1002/bmc.373 1:CAS:528:DC%2BD2cXhtVKhtrbL (Pubitemid 39591841)
6. KC Cheng C Li 2008 )Prediction of oral drug absorption in humans-from cultured cell lines and experimental animals Expert Opin Drug Metab Toxicol 4 581 590 10.1517/17425255.4.5.581 18484916 10.1517/17425255.4.5.581 1:CAS:528:DC%2BD1cXmtVWrsbY%3D (Pubitemid 351890740)
7. A Dahan GL Amidon 2009 Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein Pharm Res 26 883 892 10.1007/s11095-008-9789-7 19048359 10.1007/s11095-008-9789-7 1:CAS:528:DC%2BD1cXhsVeqs7%2FE
8. F Delie W Rubas 1997 A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model Crit Rev Ther Drug Carrier Syst 14 221 286 9282267 1:CAS:528:DyaK2sXlvFeru7c%3D (Pubitemid 27355917)
9. IJ Hidalgo TJ Raub RT Borchardt 1989 Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability Gastroenterology 96 736 749 2914637 1:STN:280:DyaL1M7itFeqsg%3D%3D (Pubitemid 19057595)
10. HY Hye L Mijin WL Min, et al. 2007 Effects of Schisandra Lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 Cells Planta Med 73 5 444 450 10.1055/s-2007-967178 10.1055/s-2007-967178 (Pubitemid 46917459)
11. EE Jeffrey RB Kenneth JM Patrick 2002 GF120918, a P-glycoprotein modulator, increases the concentration of unbound amprenavir in the central nervous system in rats Antimicrob Agents Chemother 46 7 2284 2286 10.1128/AAC.46.7.2284-2286.2002 10.1128/AAC.46.7.2284-2286.2002 (Pubitemid 34665933)
12. WY Kim LZ Benet 2004 P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro Pharm Res 21 7 1284 1293 10.1023/B:PHAM.0000033017.52484.81 15290871 10.1023/B:PHAM.0000033017. 52484.81 1:CAS:528:DC%2BD2cXltF2gsb4%3D (Pubitemid 38954215)
13. R Konsoula FA Barile 2005 Correlation of in vitro cytotoxicity with paracellular permeability in Caco-2 cells Toxicol in Vitro 19 675 684 10.1016/j.tiv.2005.03.006 15896555 10.1016/j.tiv.2005.03.006 1:CAS:528:DC%2BD2MXkt1OitL8%3D (Pubitemid 40719542)
14. Z Konsoula M Jung 2009 Involvement of P-glycoprotein and multidrug resistance associated protein 1 on the transepithelial transport of a mercaptoacetamide-based histone-deacetylase inhibitor in Caco-2 cells Biol Pharm Bull 32 74 78 10.1248/bpb.32.74 19122284 10.1248/bpb.32.74 1:CAS:528: DC%2BD1MXmsVWmtr0%3D
15. R Konsoula J Mira 2008 In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors Int J Pharm 361 19 25 10.1016/j.ijpharm.2008.05.001 18562136 10.1016/j.ijpharm.2008.05.001 1:CAS:528:DC%2BD1cXpt1alsr0%3D
16. K Lan JL He Y Tian, et al. 2008 Intra-herb pharmacokinetics interaction between quercetin and isorhamentin Acta Pharmacol Sin 29 1376 1382 10.1111/j.1745-7254.2008.00884.x 18954533 10.1111/j.1745-7254.2008.00884.x 1:CAS:528:DC%2BD1cXhtlOqtLrJ
17. YY Lau H Okochi Y Huang, et al. 2006 Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems J Pharmacol Exp Ther 316 762 771 10.1124/jpet.105.093088 16258024 10.1124/jpet.105.093088 1:CAS:528: DC%2BD28XhtlWqtrg%3D (Pubitemid 43131004)
18. YX Li XH Jiang J Zhou 2005 The absorption mechanism of phillyrin in digestive tract in rat West China J Pharm Sci 5 387 390 CNKI:SUN:HXYO.0.2005-05- 005
19. HJ Maeng HJ Yoo IW Kim, et al. 2002 P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers J Pharm Sci 91 2614 2621 10.1002/jps.10268 12434406 10.1002/jps.10268 1:CAS:528:DC%2BD38XptVeksbY%3D (Pubitemid 35379419)
20. C Meaney C O'Driscoll 1999 Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models Eur J Pharm Sci 8 167 175 10.1016/S0928-0987(99)00007-X 10379039 10.1016/S0928-0987(99)00007-X 1:CAS:528:DyaK1MXjvFCisb0%3D (Pubitemid 29324644)
21. S Nishibe K Okabe H Tsukamoto, et al. 1982 Studies on the Chinese crude drug "Forsythiae Fructus". VI. The structure and antibacterial activity of suspensaside isolated from Forsythia suspensa Chem Pharm Bull 30 4548 4553 7168874 1:CAS:528:DyaL3sXhsVSmsLY%3D (Pubitemid 13185668)
22. MD Perloff E Störmer LL Von Moltke, et al. 2003 Rapid assessment of P-glycoprotein inhibition and induction in vitro Pharm Res 20 1177 1183 10.1023/A:1025092829696 12948015 10.1023/A:1025092829696 1:CAS:528: DC%2BD3sXmtVGrtLs%3D (Pubitemid 36951842)
23. W Rubas N Zezyk GM Grass 1993 Comparison of the permeability characterization of a human colonic epithelium (Caco-2) cell line to colon of rabbit, monkey and dog intestine and human drug absorption Pharm Res 10 113 118 10.1023/A:1018937416447 8430047 10.1023/A:1018937416447 1:CAS:528: DyaK3sXntlWjsA%3D%3D (Pubitemid 23020847)
24. R Sandström A Karlsson H Lennernäs 1998 The absence of stereoselective P-glycoprotein-mediated transport of R/S-verapamil across the rat jejunum J Pharm Pharmacol 50 729 735 9720621 (Pubitemid 28379266)
25. J Taipalensuu H Tornblom G Lindberg, et al. 2001 Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial caco-2 cell monolayers J Pharmacol Exp Ther 299 164 170 0022-3565/01/2991-164-170 11561076 1:CAS:528:DC%2BD3MXntFWlt7Y%3D (Pubitemid 32905131)
26. F Tang K Horie RT Borchardt 2002 Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa? Pharmacol Res 19 773 779 10.1023/A:1016140429238 10.1023/A:1016192413308 1:CAS:528: DC%2BD38XltVSgsb8%3D (Pubitemid 34686734)
27. Z Teodoro JCC María NM Ricardo, et al. 2004 Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models Eur J Pharm Sci 22 347 356 10.1016/j.ejps.2004.04.004 10.1016/j.ejps.2004.04.004 (Pubitemid 38953893)
28. TT Tran A Mittal T Aldinger, et al. 2005 The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells Biophys J 88 715 738 10.1529/biophysj.104.045633 15501934 10.1529/biophysj.104. 045633 1:CAS:528:DC%2BD2MXjtFynu7Y%3D (Pubitemid 40070714)
29. HCL Traunecker MCG Stevens DJ Kerr, et al. 1999 The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells Br J Cancer 81 6 942 951 10.1038/sj.bjc.6690791 10576649 10.1038/sj.bjc.6690791 1:CAS:528:DyaK1MXnvFSjs78%3D (Pubitemid 29516136)
30. Wang BL (2009) The pharmacokinetics and metabolism of Chinese magnoliavine fruit [D], Peking Union Medical College 2009. doi: CNKI:CDMD:1.2009.150733
31. S Yamashita T Furubayashi M Kataoka, et al. 2000 Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells Eur J Pharm Sci 10 195 204 10.1016/S0928-0987(00)00076-2 10767597 10.1016/S0928-0987(00)00076-2 1:CAS:528:DC%2BD3cXitlOksL8%3D (Pubitemid 30190095)
32. S Yee 1997 In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth Pharm Res 14 763 766 10.1023/A:1012102522787 9210194 10.1023/A:1012102522787 1:CAS:528:DyaK2sXkt1yit7c%3D (Pubitemid 27281671)
33. YM Zhao FR Li JX Yang, et al. 2005 Effect of phillyrin on the anti-obesity in nutritive obesity mice J Chin Med Mate 2 124 125 CNKI:SUN:ZYCA.0.2005-02-00M
34. YM Zhao FR Li JX Yang, et al. 2005 Study on the reducing blood lipid and antioxidation effects of phillyrin Nat Prod Res Dev 17 36 38 CNKI:SUN:TRCW.0.2005-02-007